AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32093339 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength + endurance exercise with 25-30% caloric restriction diet
Number of subjects: 162
Study 32093339 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based physical activity with 25-30% caloric restriction diet
Number of subjects: 162
Study 32093339 — intervention group
Group type: COMPARATOR
Intervention: All groups (combined)
Number of subjects: 162
Study 35458098 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (school garden attendance)
Number of subjects: 0
Study 35458098 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual content on the human body and health)
Number of subjects: 0
Study 33781780 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous chest wall vibration with concurrent aerobic training
Number of subjects: 40
Study 33781780 — intervention group
Group type: COMPARATOR
Intervention: Sham intervention (placebo continuous chest wall vibration)
Number of subjects: 40
Study 33781780 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 40
Study 34989089 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D models (n=65)
Number of subjects: 13
Study 34989089 — intervention group
Group type: COMPARATOR
Intervention: AMIGO method (n=65)
Number of subjects: 13
Study 34989089 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D models
Number of subjects: 13
Study 32928904 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure
Number of subjects: 134
Study 33062081 — intervention group
Group type: EXPERIMENTAL
Intervention: ET + RT + NMES
Number of subjects: 42
Study 33062081 — intervention group
Group type: COMPARATOR
Intervention: ET + RT
Number of subjects: 42
Study 35885537 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubrite laryngoscope
Number of subjects: 50
Study 35885537 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope (MCL)
Number of subjects: 50
Study 33188050 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab + ipilimumab
Number of subjects: 847
Study 33188050 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 847
Study 35717200 — intervention group
Group type: EXPERIMENTAL
Intervention: ECM scaffold (small intestinal submucosa [SIS]) + intrauterine balloon
Number of subjects: 0
Study 35717200 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine balloon only
Number of subjects: 0
Study 35599465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ankle proprioceptive training with thermal stimulation (APT)
Number of subjects: 30
Study 35599465 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (Control)
Number of subjects: 30
Study 34444363 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly fantastical animations
Number of subjects: 218
Study 34444363 — intervention group
Group type: COMPARATOR
Intervention: Low-fantastical animations
Number of subjects: 218
Study 34444363 — intervention group
Group type: COMPARATOR
Intervention: Pacing
Number of subjects: 218
Study 34444363 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-related improvements
Number of subjects: 218
Study 34444363 — intervention group
Group type: EXPERIMENTAL
Intervention: Fantasy in younger children
Number of subjects: 218
Study 32221067 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM (photobiomodulation)
Number of subjects: 34
Study 32221067 — intervention group
Group type: COMPARATOR
Intervention: PBM simulation (placebo)
Number of subjects: 34
Study 35867398 — intervention group
Group type: EXPERIMENTAL
Intervention: VR nature experiences (Ripple or Happy Place)
Number of subjects: 38
Study 33098278 — intervention group
Group type: EXPERIMENTAL
Intervention: LM+SHARE
Number of subjects: 77
Study 33098278 — intervention group
Group type: COMPARATOR
Intervention: LM
Number of subjects: 77
Study 32715381 — intervention group
Group type: COMPARATOR
Intervention: ASP3652 (300 mg bid)
Number of subjects: 0
Study 32715381 — intervention group
Group type: COMPARATOR
Intervention: ASP3652 (600–1800 mg)
Number of subjects: 0
Study 32715381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34932511 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega Scanner 3D
Number of subjects: 30
Study 34932511 — intervention group
Group type: EXPERIMENTAL
Intervention: Rodin4D
Number of subjects: 30
Study 34932511 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosculptor
Number of subjects: 30
Study 34932511 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 30
Study 33676597 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin plus usual care
Number of subjects: 2265
Study 33676597 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 2265
Study 35710384 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate GWG
Number of subjects: 1230
Study 35710384 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate GWG (percentage of GWG adequacy)
Number of subjects: 1230
Study 35710384 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive GWG among women with normal BMI
Number of subjects: 1230
Study 35710384 — intervention group
Group type: COMPARATOR
Intervention: Adequate GWG
Number of subjects: 1230
Study 34843312 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based treatment (IG)
Number of subjects: 200
Study 34843312 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group (WCG)
Number of subjects: 200
Study 36187680 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic nomogram for overall survival (OS)
Number of subjects: 232
Study 36187680 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic nomogram for cancer-specific survival (CSS)
Number of subjects: 232
Study 36187680 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration curves of the nomograms
Number of subjects: 232
Study 36187680 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision curve analysis (DCA)
Number of subjects: 232
Study 36160327 — intervention group
Group type: EXPERIMENTAL
Intervention: Action Observation Therapy (AOT)
Number of subjects: 27
Study 36160327 — intervention group
Group type: COMPARATOR
Intervention: Nature videos (control)
Number of subjects: 27
Study 32311977 — intervention group
Group type: EXPERIMENTAL
Intervention: Qizhi Weitong granules (QZWTG)
Number of subjects: 384
Study 34861953 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-week education program
Number of subjects: 70
Study 34861953 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 32873533 — intervention group
Group type: EXPERIMENTAL
Intervention: Meeting sexual partners online
Number of subjects: 14537
Study 35526703 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-only sugar warning label
Number of subjects: 2219
Study 35526703 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial sugar warning label
Number of subjects: 2219
Study 35526703 — intervention group
Group type: COMPARATOR
Intervention: Barcode control
Number of subjects: 2219
Study 35526703 — intervention group
Group type: EXPERIMENTAL
Intervention: Text and pictorial sugar warning labels
Number of subjects: 2219
Study 34766912 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit Flex and biweekly phone calls with a study physiotherapist (PT) during an 8-week physical activity counseling intervention
Number of subjects: 21
Study 33130860 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized handwritten sympathy cards
Number of subjects: 393
Study 616314157 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended duration weight-loss programme referrals
Number of subjects: 0
Study 616314157 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard duration weight-loss programme referrals
Number of subjects: 0
Study 616314157 — intervention group
Group type: COMPARATOR
Intervention: Brief intervention group
Number of subjects: 0
Study 35501120 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy (LPI) in one eye
Number of subjects: 889
Study 35501120 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 889
Study 33580603 — intervention group
Group type: EXPERIMENTAL
Intervention: KRP-116D (50% dimethyl sulfoxide solution)
Number of subjects: 96
Study 33580603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 33580603 — intervention group
Group type: EXPERIMENTAL
Intervention: KRP-116D
Number of subjects: 96
Study 36217645 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam (20 mg)
Number of subjects: 120
Study 36217645 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (20 mg)
Number of subjects: 120
Study 36217645 — intervention group
Group type: COMPARATOR
Intervention: No medication (Control)
Number of subjects: 120
Study 35279317 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel off-loading boot
Number of subjects: 394
Study 35866200 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive educational video in Moroccan-Arabic, Berber, and Turkish
Number of subjects: 0
Study 35866200 — intervention group
Group type: COMPARATOR
Intervention: Current information brochure
Number of subjects: 0
Study 34303602 — intervention group
Group type: EXPERIMENTAL
Intervention: In-class intervention with parental feeding content
Number of subjects: 11
Study 34303602 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention with parental feeding content
Number of subjects: 11
Study 34303602 — intervention group
Group type: COMPARATOR
Intervention: Control group (no parental feeding content)
Number of subjects: 11
Study 32183886 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized dornase alfa
Number of subjects: 250
Study 32183886 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 35657784 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (300,000 IU)
Number of subjects: 120
Study 35657784 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33667670 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirvetuximab soravtansine (MIRV)
Number of subjects: 366
Study 35850911 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 0
Study 33513485 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6 genotype and functional status treatment
Number of subjects: 0
Study 33513485 — intervention group
Group type: COMPARATOR
Intervention: Standard psychotropic therapy
Number of subjects: 0
Study 32302640 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass fiber posts
Number of subjects: 119
Study 32302640 — intervention group
Group type: COMPARATOR
Intervention: Cast metal posts
Number of subjects: 119
Study 32302640 — intervention group
Group type: EXPERIMENTAL
Intervention: Both post types
Number of subjects: 119
Study 36151980 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain management programme
Number of subjects: 64
Study 36151980 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 64
Study 34113353 — intervention group
Group type: EXPERIMENTAL
Intervention: estradiol (E2) patch
Number of subjects: 36
Study 34113353 — intervention group
Group type: COMPARATOR
Intervention: transdermal placebo
Number of subjects: 36
Study 35614185 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitin-glucan (CG) supplementation (4.5 g daily)
Number of subjects: 15
Study 35614185 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (control)
Number of subjects: 15
Study 34089219 — intervention group
Group type: EXPERIMENTAL
Intervention: VAIA (vincristine, dactinomycin, doxorubicin, and ifosfamide) or VACA II (cyclophosphamide) in CWS-91
Number of subjects: 243
Study 34089219 — intervention group
Group type: EXPERIMENTAL
Intervention: VAIA or CEVAIE (+carboplatin and etoposide) in CWS-96
Number of subjects: 243
Study 34089219 — intervention group
Group type: EXPERIMENTAL
Intervention: VAIA III plus optional maintenance therapy (MT) in CWS-2002P
Number of subjects: 243
Study 34879312 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity tracker (Fitbit Flex 2) used for 7 days at baseline and 7 days before the 2-month follow-up assessment.
Number of subjects: 65
Study 33929522 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=3732 in phase 1, n=6645 in phase 2) received a nurse-led Joint Asia Diabetes Evaluation (JADE) technology-guided structured evaluation, automated personalized reports, and 2 or more contacts by nurses.
Number of subjects: 20834
Study 33929522 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=3805 in phase 1, n=6652 in phase 2) received the JADE technology-guided structured evaluation and automated personalized reports (phase 1) or only the JADE technology-guided structured evaluation (phase 2).
Number of subjects: 20834
Study 34522175 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-axis hydrodissection (5 mL normal saline per session)
Number of subjects: 44
Study 34522175 — intervention group
Group type: COMPARATOR
Intervention: Long-axis hydrodissection (5 mL normal saline per session)
Number of subjects: 44
Study 32593154 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-tACS
Number of subjects: 30
Study 32593154 — intervention group
Group type: COMPARATOR
Intervention: sham-tACS
Number of subjects: 30
Study 35461639 — intervention group
Group type: EXPERIMENTAL
Intervention: V block
Number of subjects: 140
Study 35461639 — intervention group
Group type: COMPARATOR
Intervention: H block
Number of subjects: 140
Study 32782323 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 73
Study 32782323 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping (ECC)
Number of subjects: 73
Study 36457653 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil (2 drops, twice a day, for four consecutive days a week, for four weeks)
Number of subjects: 80
Study 36457653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32791810 — intervention group
Group type: EXPERIMENTAL
Intervention: Cipterbin (4 mg/kg loading dose and 2 mg/kg maintenance dose each week, IV) combined with vinorelbine (25 mg/m(2) on days 1,8 and 15 of each 28 days, IV)
Number of subjects: 315
Study 32791810 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine (25 mg/m(2) on days 1,8 and 15 of each 28 days, IV)
Number of subjects: 315
Study 32791810 — intervention group
Group type: EXPERIMENTAL
Intervention: Cipterbin combined with vinorelbine
Number of subjects: 315
Study 32791810 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine
Number of subjects: 315
Study 36222438 — intervention group
Group type: EXPERIMENTAL
Intervention: ELOM-080 (4 × 1 capsule per day)
Number of subjects: 463
Study 36222438 — intervention group
Group type: EXPERIMENTAL
Intervention: ELOM-080
Number of subjects: 463
Study 36222438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 463
Study 33745481 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training (GMT) in eight sessions
Number of subjects: 25
Study 33745481 — intervention group
Group type: COMPARATOR
Intervention: Active control group (CG) with psychoeducation sessions
Number of subjects: 25
Study 33047511 — intervention group
Group type: EXPERIMENTAL
Intervention: 22-gauge atraumatic needle (Sprotte, 22GS)
Number of subjects: 151
Study 33047511 — intervention group
Group type: COMPARATOR
Intervention: 22-gauge traumatic needle (Quincke, 22GQ)
Number of subjects: 151
Study 35411076 — intervention group
Group type: EXPERIMENTAL
Intervention: AAV8‐VRC07 (5 × 10^10, 5 × 10^11, and 2.5 × 10^12 vector genomes per kilogram by intramuscular injection)
Number of subjects: 8
Study 35411076 — intervention group
Group type: EXPERIMENTAL
Intervention: AAV8‐VRC07
Number of subjects: 8
Study 32673048 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (target blood alcohol concentration of .08 g%)
Number of subjects: 448
Study 32673048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 448
Study 32416434 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder brace with forced tension and diagonal configuration
Number of subjects: 24
Study 32416434 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder brace (general)
Number of subjects: 24
Study 34668982 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib (36 mg/m2) administered on days 1, 2, 8, 9, 15, and 16 of a 28-day cycle
Number of subjects: 15
Study 34913431 — intervention group
Group type: EXPERIMENTAL
Intervention: Video instruction at home
Number of subjects: 120
Study 34913431 — intervention group
Group type: COMPARATOR
Intervention: Classic instruction by a nurse
Number of subjects: 120
Study 34742613 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported leisure time physical activity (some physical activity)
Number of subjects: 761
Study 34221933 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 29
Study 34221933 — intervention group
Group type: COMPARATOR
Intervention: Esmolol
Number of subjects: 29
Study 35769038 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP+ intervention (multicomponent training and support for nursing home staff over 8 months)
Number of subjects: 694
Study 35769038 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 694
Study 33714077 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported employment intervention for mood or anxiety disorders
Number of subjects: 261
Study 32657704 — intervention group
Group type: EXPERIMENTAL
Intervention: Predischarge transcutaneous bilirubin (TcB) screening
Number of subjects: 1858
Study 32657704 — intervention group
Group type: COMPARATOR
Intervention: Visual assessment (control)
Number of subjects: 1858
Study 33733720 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural corticosteroid injection (Methylprednisolone acetate 40 mg and 1 mL of 1% trimecaine hydrochloride injected next to the median nerve)
Number of subjects: 46
Study 33733720 — intervention group
Group type: COMPARATOR
Intervention: Peritendinous corticosteroid injection (Methylprednisolone acetate 40 mg and 1 mL of 1% trimecaine hydrochloride injected among flexor tendons away from the nerve)
Number of subjects: 46
Study 32910476 — intervention group
Group type: EXPERIMENTAL
Intervention: Lapatinib
Number of subjects: 652
Study 32910476 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab
Number of subjects: 652
Study 32910476 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall trial population
Number of subjects: 652
Study 32910476 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between treatment arms
Number of subjects: 652
Study 35420624 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 138
Study 35420624 — intervention group
Group type: COMPARATOR
Intervention: Verbal instructions (Control)
Number of subjects: 138
Study 33223073 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeons performing CEA with >10 cases/year
Number of subjects: 7331
Study 33223073 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeons performing CEA with >25 cases/year
Number of subjects: 7331
Study 33223073 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular surgeons performing >10 CEA
Number of subjects: 7331
Study 33223073 — intervention group
Group type: COMPARATOR
Intervention: Annual surgeon volume thresholds from RCTs
Number of subjects: 7331
Study 32404013 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoter variants with mutations in binding region
Number of subjects: 0
Study 32404013 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoter variants with mutations in melting region
Number of subjects: 0
Study 32404013 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoter variants with mutations in both regions
Number of subjects: 0
Study 32404013 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution of -2A to -2T
Number of subjects: 0
Study 35260570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 110
Study 35260570 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of a RAC1/RAC3 dual-target inhibitor and cetuximab
Number of subjects: 110
Study 33305109 — intervention group
Group type: EXPERIMENTAL
Intervention: Etelcalcetide + active vitamin D (group E+D)
Number of subjects: 124
Study 33305109 — intervention group
Group type: EXPERIMENTAL
Intervention: Etelcalcetide + oral calcium preparation (group E+Ca)
Number of subjects: 124
Study 33305109 — intervention group
Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 124
Study 35367787 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronomic adjuvant chemotherapy (MAC) consisting of weekly oral methotrexate (15 mg/m²) and celecoxib (200 mg orally twice daily) for 6 months
Number of subjects: 105
Study 35367787 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 105
Study 33984219 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block performed before tourniquet inflation (PreT)
Number of subjects: 0
Study 33984219 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block performed after tourniquet inflation (PostT)
Number of subjects: 0
Study 33984219 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block performed at the end of surgery after deflation of the tourniquet (PO)
Number of subjects: 0
Study 33984219 — intervention group
Group type: COMPARATOR
Intervention: All groups (PreT, PostT, PO)
Number of subjects: 0
Study 32485550 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological and physical IPV perpetration and victimization
Number of subjects: 30
Study 32485550 — intervention group
Group type: COMPARATOR
Intervention: Conflict behaviors
Number of subjects: 30
Study 34461042 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodynamic-guided management based on pulmonary artery pressure
Number of subjects: 1000
Study 34461042 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 1000
Study 34461042 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodynamic-guided management (pre-COVID-19 analysis)
Number of subjects: 1000
Study 34461042 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group (pre-COVID-19 analysis)
Number of subjects: 1000
Study 34461042 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodynamic-guided management during COVID-19
Number of subjects: 1000
Study 34461042 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group during COVID-19
Number of subjects: 1000
Study 34461042 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study analysis
Number of subjects: 1000